T Stamp Inc (NASDAQ:IDAI, EURONEXT:AIID) (dba Trust Stamp) revealed that it has struck a securities purchase agreement with a single institutional investor to buy 1,573,330 shares of common stock in a registered direct offering priced at-the-market.
In a coinciding private placement, the Atlanta-based global provider of artificial intelligence powered identity services, also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 1,573,330 shares of common stock.
Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) has told investors that the RCE-5 well on its Tapir Block in the Llanos Basin of Colombia has exceeded pre-drill expectations as one of six zones flowed at close to 700 barrels of oil per day (bopd) in testing.
The company, in a statement, said that RCE-5 – which was drilled in March and tested in April – had encountered six hydrocarbon bearing intervals, totalling 90 net feetpay, and was completed in the Carbonera C7 formation.
Kainantu Resources Ltd said it has received TSX Ventures Exchange approval for recent May River transaction as announced on April 3, 2023, As a result, the company has issued 18,000,000 common shares to the vendors as compensation for the transaction on April 13, 2023. This is a significant milestone for the cmpany, as it represents a step forward in its strategic growth plans and aligns with its commitment to creating long-term value for shareholders. As a result of the share issuance, the total number of common shares on issue has increased to 101,427,956.
Numinus Wellness Inc said it has launched a new client website at www.numinus.com as part of its branding strategy to align all wellness clinics under the Numinus brand. "Our new website serves as a key connection point to our brand and an extension of our in-clinic services, further supporting our clients throughout their journey with Numinus.Our clients' wellbeing is our number one priority, and an enhanced digital experience, including easier navigation and more efficient appointment booking tools, should allow us to provide greater support to our clients and other people seeking new mental health treatments," said Payton Nyquvest, founder and CEO, Numinus. "This initiative is the next major step towards offering more robust online support tools for clients and the sector, and brings us closer to meeting our goal of creating a secure and superior way for our community to connect, learn and heal,” he added. The new website completes the digital rebranding effort by Numinus, as all digital assets will now reflect the Numinus brand.
PharmaDrug Inc said it has $100,000 through the sale of debenture units. Each unit is comprised of a $1,000 principal amount convertible secured debenture and 20,000 common share purchase warrants. The debenture bears interest at a rate of 15% per annum payable monthly in arrears, matures one year from the date of issue and is convertible into common shares at a price of $0.05. It is secured by a general security agreement from PharmaDrug and its wholly-owned subsidiary Sairiyo Therapeutics Inc, and a pledge of the shares of Sairiyo. Each subscriber is entitled to a closing fee in the amount of 8% of their aggregate subscription price which fee was paid by way of a set off against the $1,000 unit purchase price. PharmaDrug said that 50% of the proceeds realized from the sale of the consideration received from the sale of Pharmadrug GmbH to Khiron Life Sciences Corp will be paid to the holders of the debentures. The debenture ranks pari passu with the debentures issued by the company in August 2022, and PharmaDrug has been paying down principal over the past several months and the combined balance following this round will be $609,000.